RxDoctor Payments Data

Paul Cangiano

Optometrist · Boston, MANPI 1538238787

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,613 of the $8,563 with a category attached, or 88.9%. 14 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 27.6% of the total. 2025 is the largest year on record at $2,836, 3.6 times the $795 reported in 2019. Among optometrist clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,563in general payments, 2019–2025

Across 225 payments — averaging $38.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$2K
  • Bausch & Lomb Americas Inc.$1K
  • Johnson & Johnson Surgical Vision, Inc.$989
  • Coopervision Inc.$703
  • Alcon$688
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$603
  • plus $2K from 8 others

What the payments were for

  • Consulting fees$95011%
  • Food & beverage$7,61389%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,563 in reported general payments places this provider in the 95th percentile of 1,084 optometrist providers in Massachusetts.

See all optometrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$18,156
Medicare patients
136
Services billed
349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone12$535
Timolol Maleate14$78

Paid to pharmacies, not to this prescriber.

Other optometrist in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →